Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Icelandair (E): COVID-19
Mitchell, Jordan; Sigurjonsson, Throstur Olaf; Berrone, PascualCaso SM-1703-EDirección estratégica, Gobierno corporativo, Innovación y cambioThis five-part case series considers Icelandair at a couple of key inflection points in its recent history. Case A, set in early 2017 on the airline's 80th anniversary, the airline is faced to question its strategy after its impressive seven-year run of dynamic growth and solid returns comes to a somewhat abrupt end due to extreme pricing competition and upward cost pressure. The case delves into the development of the airline and its "hybrid" bu...Desde 5,74 €
-
Icelandair (E): COVID-19
Mitchell, Jordan; Sigurjonsson, Throstur Olaf; Berrone, PascualCaso SM-1703Dirección estratégica, Gobierno corporativo, Innovación y cambioEn este caso en cinco partes se presenta a Icelandair en un par de momentos decisivos de su historia reciente. En el caso A, situado a principios de 2017, en el 80 aniversario de la aerolínea, la compañía debe plantearse su estrategia tras un período impresionante de siete años de crecimiento dinámico y buenos resultados que llega a su fin de forma más o menos brusca debido a la competencia de precios extrema y la presión de los costes al alza. E...Desde 5,74 €
-
Icelandair (A, B, C, D y E) - Teaching Note
Mitchell, Jordan; Sigurjonsson, Throstur Olaf; Berrone, PascualNota del Instructor SMT-132-EDirección estratégica, Gobierno corporativo, Innovación y cambioThis five-part case series considers Icelandair at a couple of key inflection points in its recent history. Case A, set in early 2017 on the airline's 80th anniversary, the airline is faced to question its strategy after its impressive seven-year run of dynamic growth and solid returns comes to a somewhat abrupt end due to extreme pricing competition and upward cost pressure. The case delves into the development of the airline and its "hybrid" bu...Desde 0,00 €
-
Sanofi-Aventis's Tender Offer for Genzyme
Eades, Kenneth M.; Matos, Pedro; Aleyev, Dmitriy; Xu, ChongCaso DARDEN-F-1716-EFinanzasIn October 2010, Henri Termeer, the chairman and CEO of Genzyme, received a letter from the CEO of Sanofi-Aventis announcing its intention to commence a tender offer for Genzyme. Termeer thought the offer undervalued Genzyme, given the number of promising new drugs in the company’s pipeline and the success of its current drug portfolio. The case focuses on the strategic and financial considerations of a large corporate acquisition. To estimate Ge...Desde 8,20 €
-
The Sanofi-Aventis Acquisition of Genzyme: Contingent Value Rights
Matos, Pedro; Aleyev, Dmitriy; Xu, ChongCaso DARDEN-F-1715-EFinanzasThis case is designed for MBA students in M&A or derivatives courses. In January 2011, Sanofi-Aventis was finalizing its offer terms for acquiring Genzyme. The M&A valuation disputes were about the market potential of alemtuzumab, a drug in Genzyme’s pipeline, and how quickly Genzyme could resolve some of its manufacturing issues. To bridge the gap in their estimates, advisers had suggested an up-front cash payment and a contingent value right (C...Desde 8,20 €
-
Genzyme and Relational Investors: Science and Business Collide? - Teaching Note
Eades, Kenneth M.; Matos, PedroNota del Instructor DARDEN-F-1660TN-EFinanzasTeaching note for product F-1660Desde 0,00 €
-
Dominion Gas Holdings, LLC-Anticipatory Interest Rate Hedging
Matos, Pedro; Maiden, Stephen E.Caso DARDEN-F-1754-EFinanzasThe case examines interest rate risk management at a U.S. utility company, Dominion Gas Holdings. In November 2012, as part of its new financing plan, it wanted to hedge the interest rate risk involved with the company’s 2013 planned issuance of $1 billion in debt. While the coupon rates for the planned debt were unknown as of November 2012, the company wanted to lock in its financing costs one year ahead since interest rates were at historically...Desde 8,20 €
-
Genzyme and Relational Investors: Science and Business Collide?
Eades, Kenneth M.; Matos, Pedro; Green, RickCaso DARDEN-F-1660-EFinanzasThe chairman and CEO of the Genzyme Corporation, one of the country’s top five biotechnology firms, has received a phone call requesting a meeting with the cofounder and principal of a large activist investment fund that now has a 2.6% stake in his company. Before meeting with him, the CEO is aware that he needs a strategy for dealing with this “activist” investor with a track record of forcing out CEOs.Desde 8,20 €
-
Barcelona: A Roman Village Becoming a Smart City (Abridged)
Carrasco, Carlos; Ricart, Joan Enric; Berrone, PascualCaso SM-1646-EDirección estratégica, Innovación y cambio, Tecnologías de la informaciónOn July 2, 2014, Josep Ramon Ferrer, director of the ICT and smart city strategy at Barcelona City Council, finished the second round of meetings with the companies selected to participate in the competitive dialogue to create City OS, Barcelona's operating system. City OS was one of the key milestones in Barcelona's smart city strategy. It aimed to enable the council to acquire and process data from urban operations in a rapid, efficient, effect...Desde 8,20 €
-
Vancouver: The Challenge of Becoming the Greenest City - Teaching Note
Berrone, Pascual; Ricart, Joan EnricNota del Instructor SMT-105-EDirección estratégica, Economía, Innovación y cambioThis is the suggested teaching note for the case "Vancouver: The Challenge of Becoming the Greenest City" (IESE, SM-1612-E). The case describes the Greenest City 2020 Action Plan, formally launched by the city of Vancouver in 2011, which was intended to make Vancouver the greenest city on the planet. Gregor Robertson, mayor of Vancouver, is the main champion of the ambitious strategic plan. While he has a successful past as a social entrepreneur ...Desde 0,00 €